Your browser doesn't support javascript.
loading
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL.
Yang, Kaiyun; Wang, Justin; Kanwar, Nisha; Villani, Anita; Ajani, Olufemi; Fleming, Adam; Patil, Vikas; Mamatjan, Yasin; Wei, Qingxia; Malkin, David; Shlien, Adam; Zadeh, Gelareh; Provias, John.
Afiliação
  • Yang K; Department of Neurosurgery, University of Toronto, Toronto, ON, Canada. kaiyun.yang@medportal.ca.
  • Wang J; Department of Neurosurgery, University of Toronto, Toronto, ON, Canada.
  • Kanwar N; Princess Margaret Cancer Center, MacFeeters-Hamilton Center for Neuro-Oncology Research, University of Toronto, Toronto, ON, Canada.
  • Villani A; Genome Diagnostics, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.
  • Ajani O; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Fleming A; Division of Neurosurgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.
  • Patil V; Division of Hematology/Oncology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
  • Mamatjan Y; Princess Margaret Cancer Center, MacFeeters-Hamilton Center for Neuro-Oncology Research, University of Toronto, Toronto, ON, Canada.
  • Wei Q; Princess Margaret Cancer Center, MacFeeters-Hamilton Center for Neuro-Oncology Research, University of Toronto, Toronto, ON, Canada.
  • Malkin D; Department of Engineering, Thompson Rivers University, Kamloops, BC, Canada.
  • Shlien A; Princess Margaret Cancer Center, MacFeeters-Hamilton Center for Neuro-Oncology Research, University of Toronto, Toronto, ON, Canada.
  • Zadeh G; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Provias J; Department of Laboratory Medicine and Pathobiology, The Hospital for Sick Children, Toronto, ON, Canada.
Brain Tumor Pathol ; 39(4): 225-231, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35668302
ABSTRACT
A child had been followed since infancy by our multi-disciplinary neuro-oncology clinic with annual magnetic resonance imaging (MRI) under the presumed diagnosis of encephalocraniocutaneous lipomatosis (ECCL), with clinical features including nevus psiloliparus, scalp lipoma, nodular skin tag on and coloboma of the eyelid, cortical atrophy and meningeal angiomatosis. At the age of 4, she was found to have a large temporoparietal lesion causing elevated intracranial pressure requiring surgical resection. Histopathological exam of the tumor was suggestive of an intracranial sarcoma. Sequencing analysis of the tumor revealed mutations in DICER1, KRAS and TP53. Subsequent germline testing confirmed DICER1 syndrome and revealed an insignificant FGFR1 variant at a low frequency. Methylation profile of the tumor showed the tumor clustered most closely with sarcoma (rhabdomyosarcoma-like), confirming this tumor to be a primary DICER1-sarcoma. Compared to the previously reported cases, our unique case of primary DICER1-sarcoma also demonstrated neurofilament and chromogranin positivity, and genomic instability with loss of chromosome 4p, 4q, 8p, 11p, and 19p, as well as gains in chromosome 7p, 9p, 9q, 13q, and 15q on copy variant analysis. The detailed sequencing and methylation information discovered in this unique case of DICER1-sarcoma will hopefully help further our understanding of this rare and emerging entity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Proteínas Proto-Oncogênicas p21(ras) Tipo de estudo: Diagnostic_studies Limite: Child / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Proteínas Proto-Oncogênicas p21(ras) Tipo de estudo: Diagnostic_studies Limite: Child / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article